Skip to content
Study details
Enrolling now

Seizure Rescue Medication (RM) as Part of a Comprehensive Epilepsy Self-management Package of Care

University Hospitals Cleveland Medical Center
NCT IDNCT06346262ClinicalTrials.gov data as of Apr 2026
Phase

Phase 4

Target enrollment

30

Study length

about 1.8 years

Ages

18+

Locations

2 sites in NY, OH

What this study is about

This trial is testing a treatment that includes seizure rescue medication and self-management support for people with epilepsy. The goal is to see if this approach helps manage seizures effectively.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Participate in SMART RM
  • 2.Take Valtoco Nasal Product

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
intranasal

How treatment is administered

Treatment Assignment
All receive treatment

Everyone gets the investigational treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Drug routes

intranasal

Endpoints

Secondary: Change in depressive symptoms as measure by Patient Health Questionnaire (PHQ-9), Change in epilepsy self management as measure by Epilepsy Stigma Scale (ESS), Change in functional status as measure by Short-Form Health Survey (SF-36), Change in quality of life as measure by QOLIE-31

Body systems

Neurology